BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20232485)

  • 61. Aspects of the neoplasms observed in patients with constitutional autosomal trisomy.
    Satge D; Van Den Berghe H
    Cancer Genet Cytogenet; 1996 Mar; 87(1):63-70. PubMed ID: 8646744
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Epigenetics in hematology: introduction.
    Beris P
    Semin Hematol; 2013 Jan; 50(1):15. PubMed ID: 23507480
    [No Abstract]   [Full Text] [Related]  

  • 63. Integrative Hematology: State of the Art.
    Andreazzoli F; Bonucci M
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675247
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ten Reasons Why People With Down Syndrome are Protected From the Development of Most Solid Tumors -A Review.
    Osuna-Marco MP; López-Barahona M; López-Ibor B; Tejera ÁM
    Front Genet; 2021; 12():749480. PubMed ID: 34804119
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Constitutional mosaic trisomies, mutations, and deletions in cancer: a hypothesis.
    Mark HF
    Cancer Genet Cytogenet; 2000 Aug; 121(1):103-5. PubMed ID: 10991619
    [No Abstract]   [Full Text] [Related]  

  • 66. A special issue on modern genomics in diagnostic haematology.
    Br J Haematol; 2021 Sep; 194(5):801-802. PubMed ID: 34463970
    [No Abstract]   [Full Text] [Related]  

  • 67. Stringent vaccination of cancer patients: is it that important?
    Weber T; Ljungman P
    Ann Oncol; 2018 Jun; 29(6):1348-1349. PubMed ID: 29697738
    [No Abstract]   [Full Text] [Related]  

  • 68. [Clinical and pathological observations on leukemia in children (symposium on hematology)].
    Otani T
    Nihon Ishikai Zasshi; 1966 Aug; 56(4):339-43. PubMed ID: 5951250
    [No Abstract]   [Full Text] [Related]  

  • 69. Familial patterns of hematologic precursors.
    Landgren O; Maura F
    Blood; 2021 Apr; 137(15):1992-1993. PubMed ID: 33856447
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Structural determinants of disease and their contribution to clinical and scientific progress.
    Bearn AG
    Ciba Found Symp; 1976; (44):25-40. PubMed ID: 147764
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Contributions to the hematology of childhood malignant tumors].
    LANDOLT RF
    Helv Paediatr Acta; 1946 Jul; 1(5):403-16. PubMed ID: 20290334
    [No Abstract]   [Full Text] [Related]  

  • 72. TRIGGER mechanism for haemopoietic neoplasia (leukaemia).
    Indian J Pediatr; 1958 May; 25(124):333-4. PubMed ID: 13574904
    [No Abstract]   [Full Text] [Related]  

  • 73. Minimally differentiated acute myeloid leukemia with ring/marker derived from chromosome 7 in a child with Down syndrome.
    Borges MLRDR; Soares-Ventura EM; Liehr T; Marques-Salles TJ
    Hematol Transfus Cell Ther; 2019; 41(1):84-87. PubMed ID: 30793109
    [No Abstract]   [Full Text] [Related]  

  • 74. [Not Available].
    Coquemont SD
    Rev Infirm; 2021 Mar; 70(269):51-52. PubMed ID: 33742597
    [No Abstract]   [Full Text] [Related]  

  • 75. Chronic myeloid leukemia treatment guidelines: Brazilian Association of Hematology, Hemotherapy and Cell Therapy. Brazilian Medical Association Guidelines Project - 2012.
    de Souza CA; Pagnano KB; Bendit I; Conchon M; Freitas CM; Coelho AM; Funke VA; Bernardo WM
    Rev Bras Hematol Hemoter; 2012; 34(5):367-82. PubMed ID: 23125546
    [No Abstract]   [Full Text] [Related]  

  • 76. A genomic approach to study down syndrome and cancer inverse comorbidity: untangling the chromosome 21.
    Forés-Martos J; Cervera-Vidal R; Chirivella E; Ramos-Jarero A; Climent J
    Front Physiol; 2015; 6():10. PubMed ID: 25698970
    [TBL] [Abstract][Full Text] [Related]  

  • 77. RUNX family: Oncogenes or tumor suppressors (Review).
    Otálora-Otálora BA; Henríquez B; López-Kleine L; Rojas A
    Oncol Rep; 2019 Jul; 42(1):3-19. PubMed ID: 31059069
    [TBL] [Abstract][Full Text] [Related]  

  • 78. What people with Down Syndrome can teach us about cardiopulmonary disease.
    Colvin KL; Yeager ME
    Eur Respir Rev; 2017 Jan; 26(143):. PubMed ID: 28223397
    [TBL] [Abstract][Full Text] [Related]  

  • 79. GATA1 mutations in a cohort of Malaysian children with Down syndrome-associated myeloid disorder.
    Lum SH; Choong SS; Krishnan S; Mohamed Z; Ariffin H
    Singapore Med J; 2016 Jun; 57(6):320-4. PubMed ID: 27353457
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synthetic combinations of missense polymorphic genetic changes underlying Down syndrome susceptibility.
    Jackson RA; Nguyen ML; Barrett AN; Tan YY; Choolani MA; Chen ES
    Cell Mol Life Sci; 2016 Nov; 73(21):4001-17. PubMed ID: 27245382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.